Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Value of the Levels of Circulating Tumor Cells (CTCs) in Peripheral Blood in Patients With Prostate Cancer at High Risk (Clinical Stages IIB-III) Treated Radically With Radiotherapy and Hormone Therapy.

NCT01800058 is registered in ClinicalTrials.gov with Fundación de Investigación Biomédica - Hospital Universitario de La Princesa as lead sponsor.

NCT NCT01800058
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01800058 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Value of the Levels of Circulating Tumor Cells (CTCs) in Peripheral Blood in Patients With Prostate Cancer at High Risk (Clinical Stages IIB-III) Treated Radically With Radiotherapy and Hormone Therapy.
Lead sponsor
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Phase
Observational
Overall status
Completed
Start date
January 31, 2014
Completion date
December 21, 2018
Enrollment
68 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

patients with high-risk prostate cancer